Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Fimasartan/Rosuvastatin FDC vs Coadministration
NCT02205190Phase 1Completed
- Sponsor
- Boryung
- Start
- Jul 2014
- Primary completion
- Sep 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of fimasartan and rosuvastatin in hypertension (HTN) and hypercholesterolemia (2 arms), sponsored by Boryung. Primary endpoints: Area Under the Curve to the Last Measurable Concentration and Maximum Plasma Concentration. Started Jul 2014; status: completed.
02
Drugs
fimasartanrosuvastatin
03
Conditions
hypertension (HTN)hypercholesterolemia
Beyond the preview
Go deeper on NCT02205190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02205190.